These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Design and Rationale of a Scandinavian Multicenter Randomized Study Evaluating if Once-Daily Tacrolimus Versus Twice-Daily Cyclosporine Reduces the 3-year Incidence of Chronic Lung Allograft Dysfunction After Lung Transplantation (ScanCLAD Study). Dellgren G; Lund TK; Raivio P; Leuckfeld I; Svahn J; Magnusson J; Riise GC Adv Ther; 2020 Mar; 37(3):1260-1275. PubMed ID: 31993943 [TBL] [Abstract][Full Text] [Related]
14. Disease progression in patients with the restrictive and mixed phenotype of Chronic Lung Allograft dysfunction-A retrospective analysis in five European centers to assess the feasibility of a therapeutic trial. Gottlieb J; Verleden GM; Perchl M; Valtin C; Vallee A; Brugière O; Bravo C PLoS One; 2021; 16(12):e0260881. PubMed ID: 34941934 [TBL] [Abstract][Full Text] [Related]
15. Lung Retransplantation for Chronic Rejection: A Single-Center Experience. Biswas Roy S; Panchanathan R; Walia R; Varsch KE; Kang P; Huang J; Hashimi AS; Mohanakumar T; Bremner RM; Smith MA Ann Thorac Surg; 2018 Jan; 105(1):221-227. PubMed ID: 29100649 [TBL] [Abstract][Full Text] [Related]
16. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients. Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178 [TBL] [Abstract][Full Text] [Related]
17. Detection, classification, and management of rejection after lung transplantation. Parulekar AD; Kao CC J Thorac Dis; 2019 Sep; 11(Suppl 14):S1732-S1739. PubMed ID: 31632750 [TBL] [Abstract][Full Text] [Related]
18. Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection. Sollinger H; Kaplan B; Pescovitz MD; Philosophe B; Roza A; Brayman K; Somberg K Transplantation; 2001 Dec; 72(12):1915-9. PubMed ID: 11773888 [TBL] [Abstract][Full Text] [Related]
19. Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience. Nykänen A; Raivio P; Peräkylä L; Stark C; Huuskonen A; Lemström K; Halme M; Hämmäinen P Scand Cardiovasc J; 2020 Jun; 54(3):192-199. PubMed ID: 32148103 [No Abstract] [Full Text] [Related]
20. Twelve-month effects of everolimus on renal and lung function in lung transplantation: differences in chronic lung allograft dysfunction phenotypes. Patrucco F; Allara E; Boffini M; Rinaldi M; Costa C; Albera C; Solidoro P Ther Adv Chronic Dis; 2021; 12():2040622321993441. PubMed ID: 33717427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]